Risk Behavior for Transmission of Human Immunodeficiency Virus (HIV) among HIV-Seropositive Individuals in an Urban Setting

McGowan, Joseph P.; Shah, Sanjiv S.; Ganea, Camelia E.; Blum, Steve; Ernst, Jerome A.; Irwin, Kathleen L.; Olivo, Noemi; Weidle, Paul J.
January 2004
Clinical Infectious Diseases;1/1/2004, Vol. 38 Issue 1, p122
Academic Journal
We conducted interviews with 256 human immunodeficiency virus (HIV)-infected patients who attended an HIV clinic in New York City to assess ongoing risk behaviors for HIV transmission. After learning that the result of an HIV test was positive, 106 subjects (41%) had unprotected sex, 63 (25%) had a new sexually transmitted disease diagnosis, and 38 (15%) used injection drugs. Unprotected sex was reported by 50% of women, 29% of heterosexual men (P = .006, compared with women), and 42% of men who have sex with men, and it was reported more often by persons with a history of trading sex for money or drugs (P < .001). In multivariate analysis, unprotected sex was associated with a history of trading sex for money or drugs (adjusted odds ratio [AOR], 4.0; 95% confidence interval [CI], 2.2-7.0) and use of highly active antiretroviral therapy (AOR, 1.8; 95% CI, 1.1-3.1). Ongoing risk-reduction counseling and substance abuse treatment for HIV-infected persons are needed to reduce behaviors associated with HIV transmission.


Related Articles

  • Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age. Sanders, Gillian D.; Bayoumi, Ahmed M.; Holodniy, Mark; Owens, Douglas K. // Annals of Internal Medicine;6/17/2008, Vol. 148 Issue 12, p889 

    Background: Although HIV infection is more prevalent in people younger than age 45 years, a substantial number of infections occur in older persons. Recent guidelines recommend HIV screening in patients age 13 to 64 years. The cost-effectiveness of HIV screening in patients age 55 to 75 years is...

  • Patient factors to target for elimination of mother-to-child transmission of HIV. Mnyani, Coceka N.; Simango, Adonia; Murphy, Joshua; Chersich, Matthew; McIntyre, James A. // Globalization & Health;2014, Vol. 10 Issue 1, p1 

    Background There is great impetus to achieve elimination of mother-to-child transmission of HIV (eMTCT) by 2015, and part of this is to identify factors to target to achieve the goal. This study thus identified key patient factors for MTCT in a high HIV prevalence setting in Johannesburg, South...

  • ANTIRETROVIRAL PROTEIN BINDING IN BLOOD AND SEMINAL PLASMAS. Velazquez, Norieliz De Jesus; Tirado, Grissell; Hill, Martin D. // Ethnicity & Disease;Spring2008 Supplement1, Vol. 18, pS1:65 

    The most frequent method of human immunodeficiency virus (HIV) transmission is sex with an infected partner. We conducted two studies to determine the active concentration of antiretroviral drugs needed to help improve viral suppression. One study measured free drug levels in blood and seminal...

  • Absence of Antiretroviral Therapy and Other Risk Factors for Morbidity and Mortality in Malaysian Compulsory Drug Detention and Rehabilitation Centers. Fu, Jeannia J.; Bazazi, Alexander R.; Altice, Frederick L.; Mohamed, Mahmood N.; Kamarulzaman, Adeeba; Dongsheng Zhou // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Background: Throughout Asia, people who use drugs are confined in facilities referred to as compulsory drug detention and rehabilitation centers. The limited transparency and accessibility of these centers has posed a significant challenge to evaluating detainees and detention conditions...

  • Recommendations for Incorporating Human Immunodeficiency Virus (HIV) Prevention into the Medical Care of Persons Living with HIV. Mayer, Kenneth H. // Clinical Infectious Diseases;1/1/2004, Vol. 38 Issue 1, p104 

    The estimated number of annual new human immunodeficiency virus (HIV) infections in the United States has remained at 40,000 for >10 years. Reducing the rate of transmission will require new strategies, including emphasis on prevention of transmission by HIV-infected persons. Medical care...

  • BASHH Scotland/Scottish HIV and AIDS group national audit 2009-2010: sexual health care for people living with HIV. Hembrom, R.; Goodall, L.; Bateman, V.; MacDonald, R.; Syed, A.; Taylor, R.; Clutterbuck, D. J. // International Journal of STD & AIDS;Jun2012, Vol. 23 Issue 6, p439 

    A national Scottish audit of 282 patients with HIV infection attending 11 clinics showed the following levels of performance against quality improvement Scotland Sexual Health Services Standards: syphilis serology was offered in the previous six months to 55% of patients (range: 12-97% of...

  • Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort Study. Engsig, Frederik Neess; Hansen, Ann-Brit Eg; Omland, Lars Haukali; Kronborg, Gitte; Gerstoft, Jan; Laursen, Alex Lund; Pedersen, Court; Mogensen, Christian Backer; Nielsen, Lars; Obel, Niels // Journal of Infectious Diseases;1/1/2009, Vol. 199 Issue 1, p77 

    Background. Human immunodeficiency virus (HIV) infection predisposes to progressive multifocal leukoencephalopathy (PML). Here, we describe the incidence, presentation, and prognosis of PML in HIV-1-infected patients during the period before highly active antiretroviral therapy (HAART)...

  • Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Carballo, E.; Cadarso-Suarez, C.; Carrera, I.; Fraga, J.; de la Fuente, J.; Ocampo, A.; Ojea, R.; Prieto, A.; Cadarso-Su├írez, C // Quality of Life Research;Apr2004, Vol. 13 Issue 3, p587 

    Objective: To investigate associations between health-related quality of life (HRQoL), as assessed using the multidimensional quality of life-HIV (MQOL-HIV) questionnaire, and adherence to antiretroviral treatment in HIV-infected subjects.Design: Multicentre...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Jun2009, Vol. 23 Issue 6, p485 

    The article offers news briefs related to antivirals. The Food and Drug Administration (FDA) granted tentative approval for lamivudine/zidovudine fixed dose combination tablets, co-packaged with nevirapine tablets. Early antiretroviral treatment on HIV-positive patients who seeks medical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics